The United States's largest life insurance firm by assets, Prudential Financial, felt the dual sting of the pandemic and low interest rates in 2020. The company posted its first annual loss since 2013, with final figures from 2020 showing a net loss of -$374 million. In the fourth quarter, profit plummeted by -27%, though the company still managed to post net income of $819 million. In the same quarter last year, profit was $1.13 billion.
The pandemic's impact on business is a more obvious reason major U.S. companies felt profit pressure in 2020. Less obvious is why interest falling interest rates would matter to the business. Here's why -- insurance companies like Prudential generally rely on high yielding bonds to generate interest on money being held to pay out benefits. When interest rates fall and earnings on those bonds fall with them, margins get squeezed and the insurance company is less profitable.
All insurance companies faced the same pressures as Prudential, but some fared better than others. Below, Tickeron's A.I.dvisor runs a full analysis of players in the Insurance industry, with trade ideas to go along with it. Overall, A.I.dvisor is bullish on the sector.
PUK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 61 cases where PUK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PUK advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 152 cases where PUK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on December 16, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PUK as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PUK turned negative on December 17, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .
PUK moved below its 50-day moving average on December 12, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PUK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.465) is normal, around the industry mean (1.496). P/E Ratio (15.339) is within average values for comparable stocks, (39.438). Projected Growth (PEG Ratio) (0.424) is also within normal values, averaging (0.675). Dividend Yield (0.022) settles around the average of (0.140) among similar stocks. P/S Ratio (2.179) is also within normal values, averaging (2.172).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PUK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PUK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company with interest in providing insurance and financial services
Industry LifeHealthInsurance